Recent Advances in Parkinson's Disease

What we can learn from iPSC-derived cellular models of Parkinson's disease?

Maria Claudia Caiazza, Charmaine Lang and Richard Wade-Martins

2. Animal models for preclinical Parkinson's research: An update and critical appraisal

M. Angela Cenci and Anders Bjoerklund

3. Selective neuronal vulnerability in Parkinson's disease

Patricia Gonzalez-Rodriguez, Enrico Zampese and D. James Surmeier

4. Mechanisms of alpha-synuclein toxicity: An update and outlook

Ines Caldeira Bras, Mary Xylaki and Tiago Fleming Outeiro

5. The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications

Katarzyna Z. Kuter, M. Angela Cenci and Anna R. Carta

6. Innate and adaptive immune responses in Parkinson's disease

Aubrey M. Schonhoff, Gregory P. Williams, Zachary D. Wallen, David G. Standaert and Ashley S. Harms

7. Pathways of protein synthesis and degradation in PD pathogenesis

Rebekah G. Langston and Mark R. Cookson

8. Endosomal sorting pathways in the pathogenesis of Parkinson's disease

Lindsey A. Cunningham and Darren J. Moore

9. New players in basal ganglia dysfunction in Parkinson's disease

Sara Meoni, Rubens Gisbert Cury and Elena Moro

10. Prodromal PD: A new nosological entity

Eva Schaeffer, Ronald B. Postuma and Daniela Berg

11. The gut microbiome in Parkinson's disease: A culprit or a bystander?

Ali Keshavarzian, Phillip Engen, Salvatore Bonvegna and Roberto Cilia

12. Novel approaches to counter protein aggregation pathology in Parkinson's disease

Simon R.W. Stott, Richard K. Wyse and Patrik Brundin

13. Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience

Tom Foltynie and Dilan Athauda

14. Basal ganglia oscillations as biomarkers for targeting circuit dysfunction in Parkinson's disease

Per Petersson, Andre

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Neurologia e neurofisiologia clínica
• Neurociências
• Fisiológico e neuro-psicologia, biopsicologia

Parkinson's disease; proteinopathy; alpha-synuclein; disease modeling; glia-neuron interactions; gut-brain axis; gene therapy; drug targets